Market Overview

Top 4 Small-Cap Stocks In The Biotechnology Industry With The Highest Cash

Share:
Related DNDN
8-K From Dendron Shows Approval For Order Authorizing Sale Transaction To Valeant
Form 8-K Shows Dendreon Debtors Determined Not To Select Stalking Horse Bid
Related VPHM
Aurinia Pharma Merits Speculative Buy On M&A Appeal; Phase 3 Study Remains Paramount
US Stock Futures Signal Flat Start On Wall Street

Below are the top small-cap biotechnology stocks on the NYSE and the NASDAQ in terms of cash.

Dendreon Corp (NASDAQ: DNDN) had $497.54 million in total cash and $573.82 million in total debt for the latest quarter.

ViroPharma Inc (NASDAQ: VPHM) had $473.36 million in total cash and $155.46 million in total debt for the latest quarter.

Momenta Pharmaceuticals Inc (NASDAQ: MNTA) had $382.26 million in total cash and no debt for the latest quarter.

Nektar Therapeutics (NASDAQ: NKTR) had $382.11 million in total cash and $228.85 million in total debt for the latest quarter.

Posted-In: Biotechnology Industry highest cash small-capTrading Ideas

 

Related Articles (DNDN + MNTA)

View Comments and Join the Discussion!